Company · CIK 1894562
Prime Medicine, Inc.
| CIK | 1894562 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | PRME (Nasdaq) |
| First annual or quarterly report | 2022-11-14 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291348 | 2025-11-07 | 2026-03-04 | 2 | |
| 333-275321 | 2023-11-03 | 2025-07-31 | 6 | |
| 333-283780 | 2024-12-13 | 2024-12-20 | 2 | |
| 333-267579 | 2022-09-23 | 2022-10-21 | 5 |
Filings
16| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-04 | EFFECTDeclared effective | 333-291348 | 9999999995-26-000723 |
| 2025-11-07 | S-3ASRShelf registered | 333-291348 | 0001628280-25-050428 |
| 2025-07-31 | 424B5Shelf takedown | 333-275321 | 0001628280-25-037072 |
| 2025-07-30 | 424B5Shelf takedown | 333-275321 | 0001628280-25-036721 |
| 2024-12-20 | EFFECTDeclared effective | 333-283780 | 9999999995-24-003900 |
| 2024-12-13 | S-3Shelf registered | 333-283780 | 0001628280-24-051126 |
| 2024-02-16 | 424B5Shelf takedown | 333-275321 | 0001628280-24-005201 |
| 2024-02-14 | 424B5Shelf takedown | 333-275321 | 0001628280-24-004859 |
| 2023-11-13 | EFFECTDeclared effective | 333-275321 | 9999999995-23-003310 |
| 2023-11-03 | S-3Shelf registered | 333-275321 | 0001628280-23-036792 |
| 2022-10-21 | 424B4Final prospectus | 333-267579 | 0001628280-22-026826 |
| 2022-10-19 | EFFECTDeclared effective | 333-267579 | 9999999995-22-003086 |
| 2022-10-17 | S-1/AAmendment | 333-267579 | 0001628280-22-026491 |
| 2022-10-13 | S-1/AAmendment | 333-267579 | 0001628280-22-026329 |
| 2022-09-23 | S-1Registration filed | 333-267579 | 0001628280-22-025424 |
| 2021-12-20 | DRSDraft made public | 377-05831 | 0001628279-21-000794 |